@ICR_London It’s rewarding to see the successful discovery and development of the AKT inhibitor, capivasertib which based on our AKT(PKB) crystal structure. Fantastic work!
We're proud of the major role we played in the discovery and development of the AKT inhibitor, capivasertib.
Professor David Barford's team carried out the fundamental research to reveal AKT's #3D structure (below) and how it is activated. Read more:
https://t.co/EeDB0w7kXc